Genetic deficiency of estrogen receptor alpha fails to influence experimental autoimmune myasthenia gravis pathogenesis

Journal of Neuroimmunology

Volumn 234, Issue 1-2, 2011, Pages 165-167

  Qi, Huibin ^a   Li, Jing ^a   Allman, Windy ^a   Saini, Shamsher S ^a   Tüzün, Erdem ^a   Wu, Xiaorong ^a   Estes, D Mark ^a   Christadoss, Premkumar ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Autoimmunity; Estrogen receptor alpha; Myasthenia gravis

Indexed keywords

ESTROGEN RECEPTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNITY; BIOTINYLATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE SEVERITY; GENETIC ASSOCIATION; HUMORAL IMMUNITY; IMMUNOPATHOLOGY; MOUSE; MYASTHENIA GRAVIS; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEX DIFFERENCE;

ANIMALS; ANTIBODIES; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTROGEN RECEPTOR ALPHA; GENETIC PREDISPOSITION TO DISEASE; HAND STRENGTH; IMMUNIZATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL; RECEPTORS, CHOLINERGIC; TIME FACTORS;

EID: 79955648327     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.03.002     Document Type: Article

References (19)

1. Beekman R., Kuks J.B., Oosterhuis H.J. Myasthenia gravis: diagnosis and follow-up of 100 consecutive patients. J. Neurol. 1997, 244:112-118.
2. Christadoss P., Goluszko E. Treatment of experimental autoimmune myasthenia gravis with recombinant human tumor necrosis factor receptor Fc protein. J. Neuroimmunol. 2002, 122:186-190.
3. Christadoss P., Poussin M., Deng C. Animal models of myasthenia gravis. Clin. Immunol. 2000, 94:75-87.
4. Cutolo M., Sulli A., Capellino S., Villaggio B., Montagna P., Seriolo B., Straub R.H. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 2004, 13:635-638.
5. Delpy L., Douin-Echinard V., Garidou L., Bruand C., Saoudi A., Guéry J.C. Estrogen enhances susceptibility to experimental autoimmune myasthenia gravis by promoting type 1-polarized immune responses. J. Immunol. 2005, 175:5050-5057.
6. Engdahl C., Jochems C., Windahl S.H., Börjesson A.E., Ohlsson C., Carlsten H., Lagerquist M.K. Amelioration of collagen-induced arthritis and immune-associated bone loss through signaling via estrogen receptor alpha, and not estrogen receptor beta or G protein-coupled receptor 30. Arthritis Rheum. 2010, 62:524-533.
7. Gilmore W., Weiner L.P., Correale J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J. Immunol. 1997, 158:446-451.
8. Heine P.A., Taylor J.A., Iwamoto G.A., Lubahn D.B., Cooke P.S. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc. Natl Acad. Sci. U.S.A. 2000, 97:12729-12734.
9. Leker R.R., Karni A., Brenner T., Weidenfeld J., Abramsky O. Effects of sex hormones on experimental autoimmune myasthenia gravis. Eur. J. Neurol. 2000, 7:203-206.
10. Lubahn D.B., Moyer J.S., Golding T.S., Couse J.F., Korach K.S., Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl Acad. Sci. U.S.A. 1993, 90:11162-11166.
11. Nalbandian G., Kovats S. Understanding sex biases in immunity: effects of estrogen on the differentiation and function of antigen-presenting cells. Immunol. Res. 2005, 31:91-106.
12. Qi H., Tüzün E., Allman W., Saini S.S., Penabad Z.R., Pierangeli S., Christadoss P. C5a is not involved in experimental autoimmune myasthenia gravis pathogenesis. J. Neuroimmunol. 2008, 196:101-106.
13. Rowin J., Meriggioli M.N., Tüzün E., Leurgans S., Christadoss P. Etanercept treatment in corticosteroid-dependent myasthenia gravis. Neurology 2004, 63:2390-2392.
14. Svenson J.L., EuDaly J., Ruiz P., Korach K.S., Gilkeson G.S. Impact of estrogen receptor deficiency on disease expression in the NZM2410 lupus prone mouse. Clin. Immunol. 2008, 128:259-268.
15. Tüzün E., Saini S.S., Ghosh S., Rowin J., Meriggioli M.N., Christadoss P. Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis. Neuromuscul. Disord. 2006, 16:137-143.
16. Tüzün E., Li J., Saini S.S., Yang H., Christadoss P. Targeting classical complement pathway to treat complement mediated autoimmune diseases. Adv. Exp. Med. Biol. 2008, 632:265-272.
17. Van Kempen G.T., Molenaar P.C. Effect of estradiol and progesterone on muscle weight and acetylcholine receptors in "myasthenic" rats. J. Neural Transm. Gen. Sect. 1992, 87:193-197.
18. Vincent A. Unravelling the pathogenesis of myasthenia gravis. Nat. Rev. Immunol. 2002, 2:797-804.
19. Wu B., Goluszko E., Christadoss P. Experimental autoimmune myasthenia gravis in the Mouse. Current Protocols of Immunology 1997, vol. 3:8.1:1-16. John Wiley and Sons, New York, USA. M.J. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, W. Strober (Eds.).